Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Chul Hee Kim is active.

Publication


Featured researches published by Chul Hee Kim.


Korean Diabetes Journal | 2010

The relationship of adiponectin/leptin ratio with homeostasis model assessment insulin resistance index and metabolic syndrome in apparently healthy korean male adults.

Chan-Hee Jung; Eun-Jung Rhee; Ji-Hoon Choi; Ji-Cheol Bae; Seung-Hyun Yoo; Won-Jun Kim; Cheol-Young Park; Ji Oh Mok; Chul Hee Kim; Won Young Lee; Ki-Won Oh; Sung-Woo Park; Sun-Woo Kim

Background We investigated the relationships of adiponectin/leptin (A/L) ratio with cardiovascular risk factors, insulin resistance index, and metabolic syndrome (MS) in apparently healthy Korean male adults. Methods Sixty-eight male subjects were enrolled among the participants of an annual health check-up program (mean age, 55.1 years). Percent body fat (%) was measured using a bioelectric impedance analyzer. Serum leptin level was measured via radioimmunoassay, and adiponectin level was measured using an enzyme-linked immunosorbent assay. Homeostasis model assessment (HOMA)-insulin resistance (IR) index was calculated, and the presence of metabolic syndrome was assessed. Results Adiponectin, leptin, and A/L ratio showed significant correlations with percent body fat, lipid profile, and HOMA-IR. Mean leptin and HOMA-IR levels were significantly higher, while A/L ratio was significantly lower in subjects with MS. With increasing number of MS components, the mean values of leptin and HOMA-IR increased and the A/L ratio decreased. In multiple regression analysis, HOMA-IR was significantly correlated with triglyceride, fasting glucose, and A/L ratio, while A/L ratio was significantly correlated with body mass index and HOMA-IR. HOMA-IR and A/L ratio were significant predictors for each other after adjustment for other factors. Conclusion A/L ratio correlated well with lipid profile, HOMA-IR, and the presence and number of MS components in Korean male subjects.


Journal of Korean Medical Science | 2004

Increased Expression of Focal Adhesion Kinase in Thyroid Cancer: Immunohistochemical Study

Sang-Jin Kim; Jin-Woo Park; Ji Sung Yoon; Ji O Mok; Yeo Joo Kim; Hyeong Kyu Park; Chul Hee Kim; Dong Won Byun; Yong Jin Lee; So Young Jin; Kyo Il Suh; Myung Hi Yoo

Focal adhesion kinase (FAK) is a tyrosine kinase that is found in cellular structures called focal adhesions. FAK appears to be a key element in signal transduction pathways involved in cell adhesion and locomotion. FAK is overexpressed in various tumors, including tumors derived from regions of the head and neck, colon, breast, prostate, and liver. In this study, we investigated immunohistochemically whether FAK expression was increased in thyroid cancers. FAK staining was not seen in any of the 20 normal thyroid tissues or the 6 nodular hyperplasia specimens. In contrast, FAK staining was observed in all of 17 papillary carcinomas, 9 follicular carcinomas, 8 medullary carcinomas, and 2 anaplastic carcinomas. Nine of 17 follicular adenomas showed FAK immunoreactivity. FAK was not expressed in normal tissue and nodular hyperplasia, but was expressed in some of the follicular adenoma, and all of the follicular, papillary, medullary and anaplastic thyroid carcinoma. This result indicates that the up-regulation of FAK may play a role in the development of thyroid carcinogenesis.


Yonsei Medical Journal | 2012

Impact of clinicopathologic factors on subclinical central lymph node metastasis in papillary thyroid microcarcinoma.

Bo-Yeon Kim; Chan-Hee Jung; Jae Wook Kim; Seung Won Lee; Chul Hee Kim; Sung Koo Kang; Ji Oh Mok

Purpose We evaluated whether the clinicopathological factors of papillary thyroid microcarcinoma (PTMC), especially tumoe size, are associated with subcinical central lymph node metastasis. Materials and Methods A total of 160 patients diagnosed with PTMC who underwent total thyroidectomy with bilateral central lymph node dissection were enrolled in this study. All patients were clinically lymph node negative PTMC. Patients were divided into 2 groups according to the size of tumor (≤5 mm vs. >5 mm). Clinicopathologic risk factors for subclinical central lymph node metastasis were analyzed. Results Subclinical central lymph node metastasis was detected in 61 (38.1%). Patients with tumors ≤5 mm had a lower frequency of extrathyroidal extension, multifocality and subclinical central lymph node metastasis. On multivariate analysis, only male and tumor size >5 mm were independent predictors of subclinical central lymph node metastasis; age, multifocality, bilaterality, extrathyroidal extension, lymphvascular invasion and lymphocytic thyroiditis were not. Conclusion In this study, male and tumor size >5 mm were two independent predictive factors for subclinical central lymph node metastasis in PTMC. These are easier factors to assess before surgery than other factors when planning the central lymph node dissection. However, further long-term follow-up studies are needed to confirm the prognostic significance of subclinical central lymph node metastasis in PTMC.


Progress in Nuclear Energy | 2000

THE CONCEPT OF PROLIFERATION-RESISTANT, ENVIRONMENT- FRIENDLY, ACCIDENT-TOLERANT, CONTINUAL AND ECONOMICAL REACTOR (PEACER)

Il Soon Hwang; Sook Hyang Jeong; B.G. Park; Won Sik Yang; Kune Y. Suh; Chul Hee Kim

In an effort to ameliorate generic concerns with current power reactors such as the risk of proliferation, radiological hazard of the spent fuel, and the vulnerability to core-melt accidents, the concept of a revolutionary reactor, named PEACER, has been developed as a proliferation-resistant waste transmutation reactor based on the unique combination of technologies of a proven fast reactor and the heavy liquid metal coolant. In this paper, results of the PEACER conceptual design are presented by focusing on the estimated performance of the PEACER system. The proliferation resistance of PEACER is based upon both institutional and technical issues. The latter includes denaturing of flssile materials, Pu in particular, as well as the intense radiation field associated with the pyrochemical partitioning method. When the fuel volume fraction and the core aspect ratio(L/D) are optimized, the transmutation capability of PEACER for long-lived wastes from LWR spent fuels is found to exceed the production rate of two LWR’s with the same electric rating. In contrast with current power reactor design principles, the lower power density and the higher neutron leakage rate lead to higher performance with respect to proliferation-resistance, transmutation capability and the accident-tolerance. Results of the present conceptual design show promising characteristics in all the five targets proposed by its name PEACER, which warrants more detailed study. 0 2000 Elsevier Science Ltd. All rights reserved.


Metabolism-clinical and Experimental | 1996

Effect of decreasing plasma free fatty acids by acipimox on hepatic glucose metabolism in normal rats

Ki-Up Lee; Joong Y. Park; Chul Hee Kim; S. Hong; Kyo Suh; Kyung Soo Park; Sung W. Park

Increased availability of free fatty acids (FFA) may play a role in the pathogenesis of insulin resistance in the liver. We examined the effects of an antilipolytic nicotinic acid analog (acipimox) on hepatic glucose metabolism in basal and hyperinsulinemic states in normal rats. Acipimox decreased plasma FFA levels profoundly and enhanced the ability of insulin to suppress hepatic glucose production (HGP) and to stimulate peripheral glucose utilization. In the basal state, acipimox inhibited hepatic gluconeogenesis. However, this inhibition was not associated with the change in overall HGP due to the compensatory increase in hepatic glycogenolysis that might occur as a consequence of decreased hepatic glucose-6-phosphate (G-6-P) and/or plasma insulin levels with acipimox. These results support the contention that FFA are an important determinant of insulin action in the liver, and suggest the existence of intrahepatic autoregulatory and/or hormonal regulatory processes for constant HGP in the basal state.


Endocrinology and Metabolism | 2015

Risk of Malignancy in Thyroid Incidentalomas Identified by Fluorodeoxyglucose-Positron Emission Tomography

A Reum Chun; Hye Min Jo; Seoung Ho Lee; Hong Woo Chun; Jung Mi Park; Kyu Jin Kim; Chan-Hee Jung; Ji Oh Mok; Sung Koo Kang; Chul Hee Kim; Bo-Yeon Kim

Background Thyroid incidentalomas detected by 2-deoxy-2-18F-fluoro-D-glucose positron emission tomography/computed tomography (18F-FDG PET/CT) have been reported in 1% to 4% of the population, with a risk of malignancy of 27.8% to 74%. We performed a retrospective review of FDG-avid thyroid incidentalomas in cancer screening subjects and patients with nonthyroid cancer. The risk of malignancy in thyroid incidentaloma and its association with the maximal standardized uptake value (SUVmax) in 18F-FDG PET/CT were evaluated to define the predictor variables in assessing risk of malignancy. Methods A total of 2,584 subjects underwent 18F-FDG PET/CT for metastatic evaluation or cancer screening from January 2005 to January 2010. Among them, 36 subjects with FDG-avid thyroid incidentalomas underwent further diagnostic evaluation (thyroid ultrasonography-guided fine needle aspiration cytology [FNAC] or surgical resection). We retrospectively reviewed the database of these subjects. Results Of the 2,584 subjects who underwent 18F-FDG PET/CT (319 for cancer screening and 2,265 for metastatic evaluation), 52 (2.0%) were identified as having FDG-avid thyroid incidentaloma and cytologic diagnosis was obtained by FNAC in 36 subjects. Of the subjects, 15 were proven to have malignant disease: 13 by FNAC and two by surgical resection. The positive predictive value of malignancy in FDG-avid thyroid incidentaloma was 41.7%. Median SUVmax was higher in malignancy than in benign lesions (4.7 [interquartile range (IQR), 3.4 to 6.0] vs. 2.8 [IQR, 2.6 to 4.0], P=0.001). Conclusion Thyroid incidentalomas found on 18F-FDG PET/CT have a high risk of malignancy, with a positive predictive value of 41.7%. FDG-avid thyroid incidentalomas with higher SUVmax tended to be malignant.


Yonsei Medical Journal | 2013

The Risk of Metabolic Syndrome According to the White Blood Cell Count in Apparently Healthy Korean Adults

Chan-Hee Jung; Won Young Lee; Bo-Yeon Kim; Se Eun Park; Eun-Jung Rhee; Cheol-Young Park; Ki Won Oh; Ji Oh Mok; Chul Hee Kim; Sung Woo Park; Sun Woo Kim; Sung Koo Kang

Purpose Considerable amount of interest has been focused on the positive relationship between inflammation and the metabolic syndrome (MS). However, few studies have been performed to evaluate the relationship between baseline white blood cell (WBC) count and future risk for developing MS. Therefore, we investigated whether the baseline plasma levels of WBC count could be associated with future risk for MS in apparently healthy Korean. Materials and Methods A total of 1135 subjects (781 men and 354 women with a mean age of 49 years), who underwent health examinations at Kangbuk Samsung Hospital in both 2002 and 2005 were enrolled. The presence of MS was defined using the modified criteria of the National Cholesterol Education Program Adult Treatment Panel III using BMI instead of waist circumference. Results The baseline levels of WBC count were significantly higher among incident MS cases than among subjects without MS. The relative risks of incident MS were 1.4, 3.2 and 2.7 for WBC quartiles 2, 3, and 4, respectively, when compared with the first quartile (p-value for trend <0.001). These positive associations persisted after adjustment for baseline body mass index, blood pressure, fasting glucose, high density lipoprotein-cholesterol, triglyceride and homeostatic model assessment-insulin resistance; adjusted relative risk of incident MS for the 2nd, 3rd and 4th quartile groups vs. the lowest quartile were 1.2, 2.4 and 1.7, respectively (p-value for trend =0.011). Conclusion This retrospective cohort study suggests that an elevated WBC count could be associated with incident MS, suggesting that baseline inflammation mirrored by WBC level can impact future MS development.


International Journal of Geriatric Psychiatry | 2015

The relationship between cognitive performance and insulin resistance in non‐diabetic patients with mild cognitive impairment

Tae-Eun Kim; Dong Hyun Lee; Yoon-Jeong Kim; Ji Oh Mok; Chul Hee Kim; Jeong-Ho Park; Tae-Kyeong Lee; Kwangsun Yoo; Yong Jeong; Yunhwan Lee; Sun Ah Park

Insulin resistance (IR) is a distinct and early feature of type 2 diabetes mellitus and metabolic syndrome. IR is thought to play a vital role in cognitive impairment. We conducted this study to understand the early characteristics of cognitive dysfunctions attributable to IR.


Journal of Korean Medical Science | 2014

Metastasis of Colon Cancer to Medullary Thyroid Carcinoma: A Case Report

So Jung Yeo; Kyu Jin Kim; Bo-Yeon Kim; Chan-Hee Jung; Seung Won Lee; Jeong Ja Kwak; Chul Hee Kim; Sung Koo Kang; Ji Oh Mok

Metastasis to the primary thyroid carcinoma is extremely rare. We report here a case of colonic adenocarcinoma metastasis to medullary thyroid carcinoma in a 53-yr old man with a history of colon cancer. He showed a nodular lesion, suggesting malignancy in the thyroid gland, in a follow-up examination after colon cancer surgery. Fine needle aspiration biopsy (FNAB) of the thyroid gland showed tumor cell clusters, which was suspected to be medullary thyroid carcinoma (MTC). The patient underwent a total thyroidectomy. Using several specific immunohistochemical stains, the patient was diagnosed with colonic adenocarcinoma metastasis to MTC. To the best of our knowledge, the present patient is the first case of colonic adenocarcinoma metastasizing to MTC. Although tumor-tumor metastasis to primary thyroid carcinoma is very rare, we still should consider metastasis to the thyroid gland, when a patient with a history of other malignancy presents with a new thyroid finding. Graphical Abstract


The Korean Journal of Internal Medicine | 2013

Endoscopic comparison of alendronate alone and the enteric-coated alendronate with calcitriol combination in postmenopausal Korean females.

Ji Oh Mok; Chan-Hee Jung; Chul Hee Kim; Chang Beom Ryu; Yeo Joo Kim; Sang-Jin Kim; Hyeong Kyu Park; Kyo Suh; Myung Hi Yoo; Dong Won Byun

Background/Aims This study was performed to compare the mucosal findings after esophagogastroduodenoscopy in two groups before and after the use of alendronate only and following administration of the enteric-coated alendronate (5 mg) and calcitriol (0.5 µg) combined drug (Maxmarvil, Yuyu Co.). Methods The study population consisted of 33 postmenopausal healthy female volunteers, aged 50 to 70 years (mean age, 58 ± 5) without gastrointestinal symptoms and with normal baseline endoscopic findings. Esophagogastroduodenoscopy was performed at baseline and was repeated 2 weeks later after daily intake of Maxmarvil (n = 17 subjects) or alendronate only (n = 16 subjects). Mucosal injury scores were reported by an endoscopist after 2 weeks of treatment with each medication schedule. Results Esophageal mucosal injuries developed in two of 16 subjects in the alendronate only group and 0 of 17 in the Maxmarvil group. Gastric mucosal injuries developed in eight subjects in the alendronate group and four subjects in the Maxmarvil group; this difference was statistically significant. Conclusions The mucosal damage scores for the alendronate group (total score 24) were significantly higher than those for the Maxmarvil group (total score 9) in the esophagus and stomach. Therefore, this study suggested that enteric-coated Maxmarvil is less harmful to gastrointestinal mucosa than alendronate, and may improve the tolerability of osteoporosis medication in clinical practice.

Collaboration


Dive into the Chul Hee Kim's collaboration.

Top Co-Authors

Avatar

Ji Oh Mok

Soonchunhyang University

View shared research outputs
Top Co-Authors

Avatar

Chan-Hee Jung

Soonchunhyang University

View shared research outputs
Top Co-Authors

Avatar

Dong Won Byun

Soonchunhyang University

View shared research outputs
Top Co-Authors

Avatar

Bo-Yeon Kim

Soonchunhyang University

View shared research outputs
Top Co-Authors

Avatar

Hyeong Kyu Park

Soonchunhyang University Hospital

View shared research outputs
Top Co-Authors

Avatar

Myung Hi Yoo

Soonchunhyang University

View shared research outputs
Top Co-Authors

Avatar

Sang-Jin Kim

Seoul National University

View shared research outputs
Top Co-Authors

Avatar

Sung Koo Kang

Soonchunhyang University

View shared research outputs
Top Co-Authors

Avatar

Yeo Joo Kim

Soonchunhyang University

View shared research outputs
Top Co-Authors

Avatar

Kyo Il Suh

Soonchunhyang University

View shared research outputs
Researchain Logo
Decentralizing Knowledge